Glycosylation of the murine estrogen receptor-α

被引:48
|
作者
Cheng, XG
Hart, GW
机构
[1] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA
[2] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Grad Program, Birmingham, AL 35294 USA
来源
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 2000年 / 75卷 / 2-3期
关键词
estrogen receptor; O-glycosylation; O-GlcNAc; PEST domain; post-translational modification; phosphorylation; estrogen;
D O I
10.1016/S0960-0760(00)00167-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
O-linked N-acetylglucosamine (O-GlcNAc) is a highly dynamic and abundant modification found on nuclear and cytoplasmic proteins of nearly all eukaryotes. O-GlcNAc addition is required for life at the single cell level and is analogous to protein phosphorylation in most respects. In a previous study (M.S. Jiang, G.W. Hart, A subpopulation of estrogen receptors are modified by O-linked N-acetylglucosamine. J. Biol. Chem. 270 (1997) 2421-2428), we demonstrated that a subpopulation of the murine estrogen receptor-alpha (mER-alpha) is modified by O-GlcNAc at Th-575. Here we mutated mER-alpha to convert Thr(575) and Ser(576) to Val and Ala, respectively. Surprisingly, this glycosylation-site mutant is still extensively modified by O-GlcNAc. Analyses of glycopeptides identified two additional sites of modification on mER-alpha, at Ser(10) and Thr(50) near the N-terminus. The major glycosylation sites are within or near PEST regions, suggesting that O-GlcNAc may regulate mER-alpha turnover. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 50 条
  • [21] Estrogen-Related Receptor-γ Regulates Estrogen Receptor-α Responsiveness in Uterine Endometrial Cancer
    Yamamoto, Takuro
    Mori, Taisuke
    Sawada, Morio
    Kuroboshi, Haruo
    Tatsumi, Hiroshi
    Yoshioka, Takashi
    Matsushima, Hiroshi
    Iwasaku, Kazuhiro
    Kitawaki, Jo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (09) : 1509 - 1516
  • [22] Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-α but not estrogen receptor-β
    Brouchet, L
    Krust, A
    Dupont, S
    Chambon, P
    Bayard, F
    Arnal, JF
    CIRCULATION, 2001, 103 (03) : 423 - 428
  • [23] Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor β
    Cheng, XG
    Cole, RN
    Zaia, J
    Hart, GW
    BIOCHEMISTRY, 2000, 39 (38) : 11609 - 11620
  • [24] Role of estrogen receptor-α in pharmacogenetics of estrogen action
    Herrington, DM
    CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (02) : 145 - 150
  • [25] Estrogen receptor-β:: An important player in estrogen action
    Gustafsson, JÅ
    HORMONAL CARCINOGENESIS III, 2001, : 144 - 148
  • [26] Estrogen receptor-β and the cardiovascular system
    Levin, ER
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (05): : 184 - 185
  • [27] Role of Estrogen Receptor-β in Endometriosis
    Bulun, Serdar E.
    Monsavais, Diana
    Pavone, Mary Ellen
    Dyson, Matthew
    Xue, Qing
    Attar, Erkut
    Tokunaga, Hideki
    Su, Emily J.
    SEMINARS IN REPRODUCTIVE MEDICINE, 2012, 30 (01) : 39 - 45
  • [28] Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?
    Margaret A Shupnik
    Breast Cancer Research, 9
  • [29] Estrogen receptor-β:: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?
    Shupnik, Margaret A.
    BREAST CANCER RESEARCH, 2007, 9 (03)
  • [30] Acute postischemic treatment with estrogen receptor-α agonist or estrogen receptor-β agonist improves myocardial recovery
    Vornehm, Nicholas D.
    Wang, Meijing
    Abarbanell, Aaron
    Herrmann, Jeremy
    Weil, Brent
    Tan, Jiangjing
    Wang, Yue
    Kelly, Megan
    Meldrum, Daniel R.
    SURGERY, 2009, 146 (02) : 145 - 154